Fig. 2. The hEGFRKI allele is not efficiently expressed in
epithelial tissues. (A) Expression of the endogenous mouse Egfr and
the hEGFRKI mRNAs measured by RNAse protection assay. The
analysis was performed on total RNA isolated from various organs of a
heterozygote hEGFRKI/+ male mouse employing an antisense
Egfr riboprobe, which detects both the endogenous mouse Egfr
and the hEGFRKI transcripts. In addition to 93 bp of
nonspecific sequence (broken line), this riboprobe encompasses the region of
the hEGFRKI allele bridging the Egfr mouse
promoter, the loxP site and the 5' end of the hEGFR cDNA. The
input probe and the protected fragments are depicted schematically and the
black triangle indicates the loxP site. A mouse S16 riboprobe (lower panel)
was used as an internal control for equal sample loading in each lane. (B)
Western blot analysis showing EGFR protein expression in brain and liver of
mice of different genotypes. Immunoblotting was performed on total protein
extracts using an anti-EGFR antibody recognising human and mouse EGFR and
anti-tubulin was used as a control for protein loading. (C) In vitro EGFR
autophosphorylation assay measuring EGFR protein levels. Prior to the kinase
assay, protein lysates from various organs were immunoprecipitated with an
anti-EGFR antibody recognising both the mouse and the human EGFR protein.
Equal loading of protein was verified by Coomassie Blue staining (data not
shown)